US Earnings Financial Results SEC Filings — April 07, 2026

07-04-2026

Cell Source, Inc. (CLCS) 10-K filing highlights severe financial risks, including a history of operating losses, substantial doubt about continuing as a going concern, defaults on promissory notes, and the need for additional financing. The company, an early-stage biotech with an unproven strategy, faces stock-related risks such as illiquid trading, insider voting concentration, dilution from future issuances, and penny stock status. No positive financial or operational metrics are presented, emphasizing ongoing challenges in clinical development and commercialization.

• ·Licensing milestones: Commence Phase 2 clinical trials by January 1, 2028 (with interim research sponsorship); commence Phase 3 or receive FDA/EMA Marketing Approval by January 1, 2031; First Commercial Sale within 12 months of Marketing Approval; no sales for 12+ months post-commencement triggers potential termination.
• ·License terms: Exclusive worldwide license under Licensed Information and Patents until later of last Patent expiration or 15-year period from FDA New Drug Approval; 'Orphan Drug' status extends coverage.
• ·Patent obligations: Company bears costs for infringement litigation and indemnifies Yeda.

07-04-2026

APEX Tech Acquisition Inc., a SPAC, reported a net loss of $39,322 for the three months ended February 28, 2026, a 371% worsening from the $8,349 loss in the prior three-month period, and a total net loss of $47,671 for the six months ended February 28, 2026. The company successfully completed its IPO, depositing $111,971,310 into the Trust Account from public units and adding $2,089,710 from private units, resulting in total assets of $112,555,390, up dramatically from $28,000 at August 31, 2025. Cash balance increased to $584,080, while shareholders' equity rose to $584,080 from $7,953 over the same period.

• ·Underwriter’s partial exercise of over-allotment option to purchase 1,197,131 units on February 27, 2026, resulting in 299,283 ordinary shares no longer subject to forfeiture.
• ·Forfeiture of 75,717 founder shares during the period.
• ·Sponsor retroactively increased purchase of ordinary shares from 1,725,000 to 2,875,000 for $25,000.
• ·Net cash used in operating activities: $39,671 for six months ended February 28, 2026.

07-04-2026

Cambium Networks Corp reported total revenues of $177,286 thousand for 2024, down 21.8% YoY from $226,767 thousand in 2023 (restated), with sharp declines in Point-to-Multi-Point (-23.3%) and Point-to-Point (-40.8%) segments offsetting growth in Enterprise (+13.3%); geographically, North America fell 37.4% while EMEA rose 16.7%. Gross profit margin improved to 35.5% from 33.9%, driven by better subscriptions and services margins (57.9% vs 53.8%), but operating expenses rose 2.1% to $133,342 thousand due to a $25,535 thousand impairment, widening operating loss to $(70,411) thousand from $(53,820) thousand. Net loss was stable at $(74,452) thousand versus $(74,080) thousand in 2023.

• ·R&D expenses decreased 26.5% YoY to $39,292 thousand.
• ·Sales and marketing expenses fell 14.4% YoY to $36,719 thousand.
• ·Interest expense, net rose 131.8% YoY to $5,843 thousand.
• ·Effective income tax rate improved to 2.4% from (30.9)%.

07-04-2026

Jaguar Health, Inc. reported total revenue of $11,511 thousand in 2025, down 1.5% YoY from $11,689 thousand, with net product revenue declining 1.9% to $11,339 thousand amid flat Mytesi sales (-1.4%) and Canalevia drop (-7.5%), offset by Gelclair growth of 185.7%. Operating expenses surged 35.0% to $57,419 thousand, driven by R&D up 50.9%, cost of product revenue up 93.0%, leading to operating loss widening to $45,908 thousand (up 48.9%) and net loss to $53,997 thousand (up 37.6% YoY). Cash used in operations improved to $23,686 thousand from $29,384 thousand, but net cash decreased by $170 thousand.

• ·Gross product sales total $15,325 thousand in 2025, down 0.8% YoY from $15,455 thousand.
• ·Cash used in operating activities $23,686 thousand in 2025 vs $29,384 thousand in 2024.
• ·Impairment loss on indefinite-lived intangible assets $800 thousand in 2025 (none in 2024).
• ·Net increase (decrease) in cash and restricted cash $(170) thousand in 2025 vs $1,533 thousand in 2024.

07-04-2026

UniFirst Corp reported revenues of $622,505 thousand for the thirteen weeks ended February 28, 2026, up 3.4% YoY from $602,219 thousand, and $1,243,823 thousand for the twenty-six weeks, up 3.1% YoY from $1,207,127 thousand, driven by growth in Uniform & Facility Service Solutions (+3.2% Q2) and First Aid & Safety Solutions (+12.2% Q2). However, operating income declined 16.7% YoY to $26,014 thousand in Q2 and 17.8% to $71,322 thousand in H1 due to higher cost of revenues (+2.4% Q2) and selling/admin expenses (+11.0% Q2), leading to net income drops of 16.2% to $20,484 thousand in Q2 and 18.8% to $54,847 thousand in H1. Total assets grew slightly to $2,800,398 thousand, but cash and equivalents fell to $151,794 thousand from $203,501 thousand, with H1 operating cash flow down 31.0% to $88,475 thousand.

• ·Acquisition of businesses: $14,627 thousand net cash outflow in H1 FY26 vs $5,374 thousand prior year.
• ·Capital expenditures: $77,284 thousand in H1 FY26 vs $66,086 thousand prior year.
• ·Common stock repurchases: $32,736 thousand in H1 FY26 vs $12,528 thousand prior year.
• ·Property, plant and equipment, net: $848,054 thousand as of Feb 28, 2026 vs $829,622 thousand Aug 30, 2025.

07-04-2026

Jefferies Financial Group Inc. reported total revenues of $2,871,265 thousand for the three months ended February 28, 2026, up 16.1% YoY from $2,472,864 thousand, with investment banking revenues surging 39.5% to $1,018,284 thousand and commissions up 27.5% to $367,604 thousand, though asset management fees declined 21.1% to $67,362 thousand. Net revenues increased 26.6% YoY to $2,017,130 thousand, but non-interest expenses rose 25.2% to $1,804,914 thousand, primarily due to 29.2% higher compensation and benefits at $1,085,890 thousand, resulting in net earnings of $159,346 thousand, up 16.4% YoY. Total assets stood at $74,380,490 thousand as of February 28, 2026, down 2.1% QoQ from $76,012,347 thousand.

• ·Diluted EPS of $0.70, up from $0.57 YoY.
• ·Net cash used in operating activities: $1,737,291 thousand (worsened from $2,665,165 thousand YoY).
• ·Common stock repurchases: $174,303 thousand in financing activities.

07-04-2026

07-04-2026

Skillsoft Corp. reported flat total revenues of $512,674 thousand for the twelve months ended January 31, 2026, compared to $530,994 thousand in 2025, with TDS segment revenues down 0.4% to $403,745 thousand while GK revenues declined sharply 13.2% to $108,929 thousand. Operating loss margin worsened to 17.5% from 13.1% in 2025, driven by a 6.2% impairment charge and 4.4% higher total operating expenses as a percentage of revenues; net loss margin expanded to 27.3% from 23.0%. Despite these declines, margins improved significantly from 2024 levels (operating loss 55.7%, net loss 63.1%).

• ·Impairment of goodwill and intangible assets represented 6.2% of revenues in FY2026 vs 0.0% in FY2025.
• ·TDS business unit contribution margin declined to 69.1% from 69.7% YoY.
• ·GK business unit contribution margin declined to 35.2% from 40.0% YoY.
• ·Critical audit matters identified for TDS Enterprise SaaS subscription revenue ($403.7M) and indefinite-lived trademark impairment.

07-04-2026

Phoenix Education Partners, Inc. reported net revenue of $222,461 thousand for the three months ended February 28, 2026, down 0.4% YoY from $223,406 thousand, with operating income declining 28.8% to $14,006 thousand due to higher general and administrative expenses ($98,105 thousand vs. $90,428 thousand) despite lower instructional costs. For the six months ended February 28, 2026, revenue increased 1.4% YoY to $484,488 thousand, but net income attributable to the company dropped sharply 58.0% to $26,234 thousand from $62,541 thousand amid elevated strategic alternatives, restructuring, and other costs ($19,736 thousand vs. $11,049 thousand). The balance sheet strengthened with total assets rising to $546,394 thousand from $493,562 thousand as of August 31, 2025, driven by higher cash ($194,597 thousand, up 42.6%) and operating cash flow of $79,954 thousand.

• ·Equity structure transitioned from limited partners ($246,735 thousand as of August 31, 2025) to common stock ($291,126 thousand Phoenix equity as of February 28, 2026).
• ·Common stock dividend of $0.21 per share and equivalents totaling $8,345 thousand in three months ended February 28, 2026.
• ·Net cash used in investing activities $8,993 thousand for six months ended February 28, 2026, primarily property and equipment purchases.
• ·Provision for credit losses on accounts receivable $16,075 thousand for six months ended February 28, 2026 (down from $23,354 thousand YoY).

07-04-2026

Cintas Corp reported robust Q3 FY2026 results with total revenue of $2,841,444 thousand, up 8.9% YoY from $2,609,159 thousand, driven by uniform rental and facility services (+7.8%) and other revenue (+12.9%), while net income rose 8.5% YoY to $502,496 thousand. For the nine months ended February 28, 2026, revenue increased 8.9% YoY to $8,359,558 thousand and net income grew 9.2% to $1,488,979 thousand, with diluted EPS at $3.65 versus $3.31 prior year. However, cash and equivalents declined to $183,204 thousand from $243,428 thousand YoY and $263,973 thousand at fiscal year-start, reflecting $933,227 thousand in share repurchases, $520,850 thousand in dividends, and $299,107 thousand in capital expenditures.

• ·Capital expenditures nine months: $299,107 thousand vs $294,260 thousand prior year (+1.6%).
• ·Acquisitions of businesses nine months: $102,685 thousand vs $198,808 thousand prior year (decline).
• ·Diluted EPS three months: $1.24 vs $1.13 YoY (+9.7%).
• ·Dividends declared per share nine months: $1.35 vs $1.17 YoY (+15.4%).
• ·Total shareholders' equity: $4,788,383 thousand vs $4,684,481 thousand at May 31, 2025 (+2.2%).
• ·Short-term debt: $229,490 thousand (new issuance of commercial paper).

07-04-2026

For the three months ended February 28, 2026, Kura Sushi USA reported sales of $80,018 thousand, up 23.3% YoY from $64,894 thousand, with operating loss narrowing to $2,228 thousand from $4,589 thousand; however, for the six months ended February 28, 2026, sales grew 18.6% YoY to $153,473 thousand but net loss remained relatively flat at $4,772 thousand versus $4,742 thousand prior year. Total assets expanded to $460,980 thousand, driven by higher property and equipment, but cash and equivalents declined to $26,605 thousand from $47,498 thousand at August 31, 2025, and stockholders' equity dipped slightly to $228,811 thousand. Operating cash flow for the six months was $8,090 thousand, down slightly from $8,623 thousand YoY.

• ·Property and equipment – net increased to $193,356 thousand from $171,190 thousand.
• ·Operating lease right-of-use assets rose to $175,157 thousand from $146,416 thousand.
• ·Payments for property and equipment in six months: $29,256 thousand.
• ·Net cash used in investing activities: $29,056 thousand for six months 2026 vs $39,396 thousand in 2025.

07-04-2026

For the three months ended February 28, 2026, Greenbrier's revenue fell 23% YoY to $587.5M from $762.1M, driven by a 24% drop in manufacturing revenue to $541.5M, while leasing revenue declined 6% to $46.0M; net earnings dropped sharply to $13.9M from $46.2M. Over the six months ended February 28, 2026, revenue decreased 21% YoY to $1,293.6M from $1,638.0M with manufacturing down 22% to $1,198.5M but leasing slightly up 1% to $95.1M, and net earnings attributable to Greenbrier fell 52% to $51.4M from $107.2M. Positively, cash provided by operating activities surged to $234.9M from $28.5M, increasing cash and equivalents to $521.8M from $306.1M sequentially.

• ·Capital expenditures for six months ended February 28, 2026: $87.6M, down from $126.4M YoY.
• ·Proceeds from sales of assets for six months: $122.2M vs $55.6M YoY.
• ·Cash dividends declared: $0.64 per share for six months ($20.4M total).
• ·Stock repurchases: $13.3M for six months.
• ·Total equity: $1,720.1M as of February 28, 2026, up from $1,697.7M at August 31, 2025.

07-04-2026

Thunder Power Holdings reported zero revenues for both 2025 and 2024, with net loss improving to $2,119,417 from $2,502,351 YoY due to reduced general and administrative expenses of $1,917,739 versus $2,502,190. However, cash used in operating activities worsened to $1,514,036 from $1,227,253, resulting in year-end cash declining sharply to $10,093 from $52,616, while shareholders' equity fell to $4,815,748 from $6,523,627 amid ongoing reliance on related party financing.

• ·Promissory notes to Mr. Wellen Sham: $560,000 (FLFV extension) + $2,575,824 (operations) + $28,000 (expenses) + $219,761 interest, maturing through Dec 2026 at 8-10%.
• ·Promissory notes to Ms. Ling Houng Sham: $300,000 (FLFV extension) + $30,751 interest, maturing through Mar 2026 at 8%.
• ·Unsettled FLFV Sponsor promissory notes: $190,000 ($50,000 due on Business Combination closing, $140,000 due Jun 21, 2024).
• ·Amount due to related parties increased to $3,457,834 as of Dec 31, 2025 from $1,766,287.

07-04-2026

Security Midwest Bancorp's total assets grew 19.6% YoY to $256,519 thousand, with net loans up 4.2% to $117,817 thousand, net interest income increasing 10.5% to $7,933 thousand, and asset quality improving markedly as non-performing loans fell to 0.27% from 1.08% of total loans. However, net income declined 56.2% to $299 thousand amid a 21.1% drop in noninterest income to $1,560 thousand and a 10.4% rise in noninterest expenses to $9,034 thousand driven by 36.0% higher salaries, resulting in ROA of 0.14% (down from 0.32%) and ROE of 1.63% (down from 4.63%). Capital ratios strengthened, with total capital to risk-weighted assets at 20.72% versus 16.85%.

• ·Nonaccrual loans totaled $317 thousand at Dec 31, 2025 (down from $1,232 thousand).
• ·Provision for credit losses was $41 thousand in 2025 (up slightly from $39 thousand).
• ·Loss on sale of investment securities was $419 thousand in 2025.
• ·Shareholders' equity increased to $22,616 thousand from $13,951 thousand.

07-04-2026

For the three months ended February 28, 2026, Londax Corp. reported revenues of $8,405, a 36% YoY decline from $13,165, with gross profit down 17% to $8,405, but net income rose to $7,296 from $1,302 driven by $12,000 other income despite higher operating expenses of $13,109. Over nine months, revenues plunged 70% YoY to $19,918 from $66,410, leading to a net loss of $33,089 versus a $24,052 profit, amid sharply higher operating expenses of $64,956. Total assets fell to $68,561 from $93,308 as of May 31, 2025, with operating cash flows shifting to a $41,859 use from $76,521 provided.

• ·Common stock shares reduced from 5,231,135 to 2,231,135 via cancellation of 3,000,000 shares.
• ·Related party loan increased to $49,485 from $4,281.
• ·No provision for income taxes in all periods.
• ·Cash and equivalents increased $3,345 over nine months to $13,951.

07-04-2026

Amplara Corp reported its first revenue of $1,129 for both the three and six months ended February 28, 2026, compared to $0 in the prior year periods. However, the company incurred a net loss of $21,660 for the three months and $43,954 for the six months, driven by total operating expenses of $22,789 and $45,083 respectively, with no prior year expenses. Cash and equivalents increased to $2,630 from $190 at August 31, 2025, supported by $72,718 in financing activities including related party loans, though operating cash flow was negative at $(37,519).

• ·Capitalization of Software Development Costs: $32,759 (investing activity for six months ended February 28, 2026)
• ·Net cash used in operating activities: $(37,519) for six months ended February 28, 2026
• ·Accumulated Deficit increased to $(53,354) as of February 28, 2026 from $(9,400) as of August 31, 2025
• ·Common Stock par value: $0.001, 75,000,000 shares authorized

07-04-2026

QuoteMedia Inc reported total licensing revenue of $20,253,917 for the year ended December 31, 2025, up 8% YoY from $18,742,252, driven by 14% growth in Corporate Quotestream to $8,242,495, while Individual Quotestream remained flat at 0% growth with $1,834,064. Gross profit increased 7% to $9,479,934 with a steady 47% margin, however total operating expenses rose 14% to $11,579,142, primarily due to a 58% surge in software development costs to $5,014,341, and other income/expenses swung to a loss of $170,692 from a $101,228 gain.

• ·Foreign exchange gain (loss) of $(116,737) in 2025 vs gain of $103,736 in 2024.
• ·Interest expense increased to $(53,955) in 2025 from $(2,508) in 2024.
• ·Weighted average exercise price: $0.04 for stockholder-approved plans, $0.03 for non-approved plans.